Lv4
534 积分 2025-09-15 加入
Chemoimmunotherapy in Deficient DNA Mismatch Repair Metastatic Colorectal Cancer: What COMMIT Can and Cannot Tell Us
11天前
已关闭
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
19天前
已完结
PI3K/AKT通路的激活促进HER2阳性胃癌曲妥珠单抗的耐药
19天前
已完结
Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial
22天前
已完结
Sibeprenlimab in IgA Nephropathy — Interim Analysis of a Phase 3 Trial
4个月前
已完结
A Phase 3 Trial of Atacicept in Patients with IgA Nephropathy
4个月前
已完结
BAFF AND APRIL: a tutorial on B cell survival
5个月前
已完结
Antibiotics for preventing meningococcal infections
5个月前
已完结
Tiny warriors, big impact: Targeted immunotherapy in kidney diseases
5个月前
已关闭
IgA nephropathy
5个月前
已完结
皖公网安备34019202002308
